Table 4.
Temporal Trends in Guideline‐Recommended Therapies
| 2008 | 2010 | 2013 | 2016 | P Trend | |
|---|---|---|---|---|---|
| Entire cohort | |||||
| n | 1716 | 1720 | 1665 | 1724 | |
| PCI during hospitalization | 1192 (69.5) | 1241 (72.2) | 1164 (69.9) | 1249 (72.4) | 0.1 |
| Statins at discharge | 1548 (91.9) | 1618 (95.0) | 1535 (92.3) | 1587 (97.8) | <0.001 |
| DAPT at discharge | 1298 (75.6) | 1421 (82.6) | 1368 (82.2) | 1446 (83.9) | <0.001 |
| Cardiac rehabilitation referral | 749 (45.8) | 864 (53.0) | 623 (50.9) | 896 (60.5) | <0.001 |
| Low risk | |||||
| n | 641 | 599 | 569 | 609 | |
| PCI during hospitalization | 503 (78.5) | 489 (81.6) | 443 (77.9) | 475 (78.0) | 0.5 |
| Statins at discharge | 598 (93.6) | 573 (95.8) | 524 (92.1) | 576 (98.5) | 0.006 |
| DAPT at discharge | 527 (82.2) | 535 (89.3) | 487 (85.6) | 542 (89.0) | 0.006 |
| Cardiac rehabilitation referral | 325 (52.9) | 358 (61.8) | 261 (61.3) | 364 (67.3) | <0.001 |
| Intermediate risk | |||||
| n | 433 | 462 | 437 | 458 | |
| PCI during hospitalization | 312 (72.1) | 355 (76.8) | 325 (74.4) | 350 (76.4) | 0.2 |
| Statins at discharge | 407 (94.9) | 441 (96.3) | 411 (94.3) | 434 (98.9) | 0.01 |
| DAPT at discharge | 332 (76.7) | 390 (84.4) | 369 (84.4) | 392 (85.6) | <0.001 |
| Cardiac rehabilitation referral | 201 (47.3) | 242 (54.8) | 174 (51.9) | 259 (66.4) | <0.001 |
| High risk | |||||
| n | 642 | 659 | 659 | 657 | |
| PCI during hospitalization | 377 (58.7) | 397 (60.2) | 396 (60.1) | 424 (64.5) | 0.04 |
| Statins at discharge | 543 (88.0) | 604 (93.2) | 600 (91.2) | 577 (96.3) | <0.001 |
| DAPT at discharge | 439 (68.4) | 496 (75.3) | 512 (77.7) | 512 (77.9) | <0.001 |
| Cardiac rehabilitation referral | 223 (37.4) | 264 (43.4) | 188 (40.7) | 273 (49.6) | <0.001 |
Values are presented as n (%). DAPT indicates dual‐antiplatelet therapy; PCI, percutaneous coronary intervention.